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INTRODUCTION
Influenza A viruses (IAV) cause highly contagious 
respiratory disease in many species including humans 
and swine. This viral agent is currently undergoing 
rapid evolution within the U.S. swine population where 
it is endemic.4 Agricultural fairs provide a swine-human 
interface suitable for interspecies transmission of IAVs, 
which are spread by droplets, through the air, and 
through direct contact. When an IAV strain normally 
circulating in swine infects a human, it is termed 
‘variant’ (v).3 In the U.S. since 2011, there have been 
345 human cases of H3N2v, resulting in 20 
hospitalizations and one death. Nearly one third of 
these cases occurred in association with exhibition 
swine at agricultural fairs in Ohio.1
Conducting active surveillance for IAV in exhibition 
swine allows for the investigation of contemporarily
circulating IAVs but does not provide evidence for IAV 
history. Antibody detection is needed to gain insight 
into previous IAV exposure in this swine population, 
whether it be due to natural infection or vaccination.
METHODS RESULTS DISCUSSION
Detection of antibodies against IAV indicate that Ohio 
exhibition swine have been previously exposed to IAV 
prior to entering the agricultural fair. The naïve 
immune systems of the general public visiting 
agricultural fairs are at risk to IAV exposure through 
infected swine contact. Therefore, slowing intra- and 
inter-species transmission of IAV benefits both swine 
and public health. It was not required that the swine at 
this agricultural fair be vaccinated against IAV. 
CONCLUSIONS
The increase in prevalence of antibodies against IAV 
in 2014 and 2015 could be due to:
• An increase in IAV vaccine use in the exhibition 
swine population
• An increase in exposure to IAV prior to swine 
entering the agricultural fair
FUTURE DIRECTIONS
Determining whether previous IAV exposure is due 
to natural infection or vaccination to answer the 
following questions:
• How well do these antibodies protect exhibition 
swine against IAV infection?
• Can IAV vaccines be made more effective at 
slowing transmission of IAV between swine?
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OBJECTIVE
To estimate the prevalence of influenza A virus 
antibodies present in exhibition swine sera at one Ohio 
agricultural fair, 2011 – 2015.
Figure 1. Sera Results 2011-2015
Year
No. 
Samples 
Collected
No. 
Positive
For IAV 
Antibodies
Percent
IAV 
Isolation 
Positive
Percent
Positive 
IAV
Antibodies
2011 43 23 58% 51%
2012 40 18 68% 45%
2013 40 11 23% 28%
2014 40 33 65% 83%
2015 26 25 0% 96%
TOTAL 189 110 45% 58%
• Blood was collected from exhibition swine 
• Serum separated by centrifugation of clotted 
blood samples
Collection and Preparation of 
Samples
• Tested for antibodies against IAV 
nucleoprotein using IDEXX AI MultiS-Screen 
Ab Test using the manufacturer’s protocol.2
Enzyme-Linked Immunosorbent 
Assay (ELISA)
• Plate absorbance read using spectrometer
• Mean absorbance calculated for positive 
and negative control to validate test
• Sample absorbance readings used to 
calculate sample to negative (S/N) ratio for 
each sample to determine if positive or 
negative
• Positive samples have an S/N ratio ≤ 0.9
• Strong positives have an S/N ratio ≤ 0.5
• Weak positives have an S/N ratio of 0.51 to 
0.9
Data Analysis
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• 58% total prevalence of antibodies against IAV 
from 2011-2015
• Parallel study on active IAV surveillance at same 
agricultural fair allows for comparison of virus 
isolation and prevalence of antibodies against IAV
• Significant increase in prevalence of 
antibodies against IAV in recent years, 2014-
2015, using a two-sided z-test
Figure 2. Swine Sera S/N Ratios 2011-2015
